(R)-2,3-Dihydro-benzo[1,4]dioxine-2-carboxylic acid, 98.0%, 250mg

Potassium dihydrogen phosphate, min. 98%, Ph.Eur., BP, 1 kg, plastic packaging.

2-Bromo-4-fluorobenzotrifluoride, 98.0%, 25g

(S)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity), 97%, 50mg

3-Chloro-1-methylpyridin-1-ium perchlorate, 250mg

1-(3-Hydroxyphenyl)propan-1-one, 95.0%, 100g

(1S,2S)-2-METHOXYCARBONYLCYCLOBUTANECARBOXYLIC ACID, 95%, 5g

Trypsin inhibitor, 250 mg

METHYL 2-(3-(HYDROXYMETHYL)CYCLOBUTYL)ACETATE, 95.0%, 250mg

N-(4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)acetamide hydrochloride, 95.0%, 250mg

Narrow mouth bottle 301, 100 ml, 18 mm, 20 Piece(s)

4-(2-CHLORO-6-METHYLTHIENO[3,2-D]PYRIMIDIN-4-YL)MORPHOLINE, 95.0%, 1g

trans-(1S,2R)-2-(3-Methoxyphenyl)cyclopropanamine hydrochloride, 500mg